A Randomized, Open-label, Parallel Group, Multi-center, Comparative, Phase IV Trial of Levetiracetam (LEV) Versus Topiramate (TPM) as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures
收藏DataCite Commons2026-03-18 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006530/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To assess the long-term effects of levetiracetam on retention rate in subjects with
refractory partial onset seizure that are not fully controlled with 1 to 3 concomitant
antiepileptic drugs, compared to topiramate as add-on therapy during 52 weeks.
提供机构：
Vivli
创建时间：
2020-12-22
